H.B. Fuller (FUL) Stock Looks Cheap Based On Future Cash Flow

H.B. Fuller shares have drifted lower in recent years, and with the stock down meaningfully over a 5 year window, the key issue now is whether the current price lines up with the cash the business is expected to generate. With fresh headlines around portfolio moves and insider buying, the question is how those decisions feed into the intrinsic value implied by its future cash flows.

• H.B. Fuller has fallen 24.8% over the last 5 years, which puts the focus squarely on whether the share price now matches the cash the business can realistically produce over time.
• The board’s decision in 2026 to reject Ancora’s US$1.2b to US$1.4b offer for the Building Adhesive Solutions unit, while exploring sales of less central assets, may support cash flow by keeping a key segment in house and using any eventual proceeds to reduce debt.
• What if you looked at H.B. Fuller through its earnings instead? See why H.B. Fuller's 13.5x P/E tells a different valuation story.

The issue now is whether H.B. Fuller’s recent share price around US$49.61 is adequately explained by the intrinsic value suggested by a Discounted Cash Flow (DCF) view of its future cash flows.

If you want to stress test the same cash flow question you are asking of H.B. Fuller across a wider field, scan through 29 high quality undervalued stocks.

Is H.B. Fuller a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) model looks at the cash H.B. Fuller can return to shareholders over time and discounts it back to today. On this view, the business is being valued on the stream of cash it can realistically produce rather than headline earnings or recent share price moves.

H.B. Fuller generated about $144.3 million of free cash flow over the last twelve months, and the DCF framework assumes that this cash generation grows from that base over the coming decade. The projections point to a growing, but steady, free cash flow profile rather than a boom and bust pattern, which usually fits a mature industrial group better than an early stage growth story. Despite the board’s decision to reject Ancora’s offer for the Building Adhesive Solutions segment and explore sales of less central units, the current share price of $49.61 still sits below what the DCF cash flow stream suggests the business could be worth. Find out what H.B. Fuller could be worth using our Discounted Cash Flow (DCF) estimate.

The H.B. Fuller Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the valuation question for H.B. Fuller leaves off, by spelling out what kind of future growth, margins and earnings path would need to unfold for the stock to trade materially above or below today’s level. These narratives sit on the Community page for the company. Rather than relying on a single multiple or model result, each narrative sets out the assumptions behind its fair value so you can compare them with actual results as they are reported.

One of the top community narratives on H.B. Fuller: 27% undervalued

"The main execution priority is integrating AMS and other medical assets while delivering the targeted manufacturing footprint reductions and conversion cost savings..."

Discover why this Narrative puts H.B. Fuller at 27% undervalued.

One more H.B. Fuller check that belongs beside the cash flow math

Before getting comfortable with H.B. Fuller purely on projected cash generation, it helps to look at the specific risk checks our research has flagged and weigh those alongside the valuation work already done. Take a closer look at 1 major warning sign before settling on a valuation.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com